-+ 0.00%
-+ 0.00%
-+ 0.00%
◇The Nikkei Stock Exchange reports that Chugai Pharmaceutical is in a buying mood, as the U.S. FDA has approved Eli Lilly's oral obesity drug.
Share

Please log in to view news

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending